Identification of a novel role of Septin 10 in paclitaxel-resistance in cancers through a functional genomics screen

Cancer Science

Volumn 103, Issue 4, 2012, Pages 821-827

  Xu, Mingli ^a   Takanashi, Masakatsu ^a   Oikawa, Kosuke ^a,b   Nishi, Hirotaka ^a   Isaka, Keiichi ^a   Yoshimoto, Takayuki ^a   Ohyashiki, Junko ^a   Kuroda, Masahiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZIMIDAZOLE DERIVATIVE; PACLITAXEL; SEPTIN; SEPTIN 10; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN GENOME; MICROTUBULE; MOLECULAR STABILITY; PHARMACOGENOMICS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BENZIMIDAZOLES; CASPASE 3; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NEOPLASMS; PACLITAXEL; SEPTINS;

EID: 84859006925     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2012.02221.x     Document Type: Article

References (27)

1. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4: 253-65.
2. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48-58.
3. Giannakakou P, Sackett DL, Kang YK et al. Paclitaxel-resistant human ovarian cancer cells have mutant beta-tubulins that exhibit impaired paclitaxel-driven polymerization. J Biol Chem 1997; 272: 17118-25.
4. Gonzalez-Garay ML, Chang L, Blade K, Menick DR, Cabral F. A beta-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J Biol Chem 1999; 274: 23875-82.
5. Kavallaris M, Kuo DY, Burkhart CA et al. Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J Clin Invest 1997; 100: 1282-93.
6. Goncalves A, Braguer D, Kamath K et al. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc Natl Acad Sci USA 2001; 98: 11737-42.
7. Zhou J, O'Brate A, Zelnak A, Giannakakou P. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol. Cancer Res 2004; 64: 8708-14.
8. Xu M, Takanashi M, Oikawa K et al. USP15 plays an essential role for caspase-3 activation during Paclitaxel-induced apoptosis. Biochem Biophys Res Commun 2009; 388: 366-71.
9. Field CM, Kellogg D. Septins: cytoskeletal polymers or signalling GTPases? Trends Cell Biol 1999; 9: 387-94.
10. Kinoshita M. Assembly of mammalian septins. J Biochem 2003; 134: 491-6.
11. Kinoshita M. The septins. Genome Biol 2003; 4: 236.
12. Hall PA, Russell SE. The pathobiology of the septin gene family. J Pathol 2004; 204: 489-505.
13. Hall PA, Jung K, Hillan KJ, Russell SE. Expression profiling the human septin gene family. J Pathol 2005; 206: 269-78.
14. Kartmann B, Roth D. Novel roles for mammalian septins: from vesicle trafficking to oncogenesis. J Cell Sci 2001; 114: 839-44.
15. Kremer BE, Haystead T, Macara IG. Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Mol Biol Cell 2005; 16: 4648-59.
16. Sui L, Zhang W, Liu Q et al. Cloning and functional characterization of human septin 10, a novel member of septin family cloned from dendritic cells. Biochem Biophys Res Commun 2003; 304: 393-8.
17. MacKeigan JP, Murphy LO, Blenis J. Sensitized RNAi screen of human kinases and phosphatases identifies new regulators of apoptosis and chemoresistance. Nat Cell Biol 2005; 7: 591-600.
18. Moffat J, Grueneberg DA, Yang X et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 2006; 124: 1283-98.
19. Ngo VN, Davis RE, Lamy L et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 2006; 441: 106-10.
20. Whitehurst AW, Bodemann BO, Cardenas J et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007; 446: 815-9.
21. Lee KH, Yim EK, Kim CJ, Namkoong SE, Um SJ, Park JS. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol 2005; 98: 45-53.
22. Frankel A, Buckman R, Kerbel RS. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids. Cancer Res 1997; 57: 2388-93.
23. Kikuno N, Moriyama-Gonda N, Yoshino T et al. Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells. Cancer Res 2004; 64: 7526-32.
24. Rowinsky EK. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med 1997; 48: 353-74.
25. Kutuk O, Letai A. Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737. Cancer Res 2008; 68: 7985-94.
26. Choi JH, Sheu JJ, Guan B et al. Functional analysis of 11q13.5 amplicon identifies Rsf-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res 2009; 69: 1407-15.
27. Galletti E, Magnani M, Renzulli ML, Botta M. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. ChemMedChem 2007; 2: 920-42.